Exploring Red Blood Cell Disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational program, GR-Ex, is designed to enhance understanding of red blood cell physiology, erythropoiesis, and iron metabolism. It involves biological sampling from participants who have red blood cell disorders or a family history of such conditions. The initiative aims to develop innovative therapeutic protocols that could improve treatment outcomes for these disorders. The study is supported by the French Ministry of Higher Education and Research as part of a Laboratory of Excellence program.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* To be affected or have a family history of disease bound to the red blood cell,
* For adult subjects, have signed an informed consent form,
* For minor or major under legal safeguard subjects, the form must be signed by both parents (for minors) or by the legal representative,
* Be affiliated to health insurance.

Exclusion Criteria:

* Being deprived of freedom

Where it's running

• CHU Amiens-Picardie
  Amiens, France Recruiting
• Hôpital Privé d'Antony
  Antony, France Recruiting
• Hôpital Avicenne
  Bobigny, France Recruiting
• Hôpital Pellegrin
  Bordeaux, France Recruiting
• Hôpital Beaujon
  Clichy, France Recruiting
• Hôpital Louis Mourier
  Colombes, France Recruiting

Study contacts

• Study coordinator: Sandra Manceau, PhD
• Email: sandra.manceau@aphp.fr
• Phone: +33171196435

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nonmyeloablative stem cell transplant for children with sickle cell disease and incompatible donors

  This study is testing a new way to do a stem cell transplant for children with sickle cell disease who have a donor that doesn't perfectly match to see if it can help them get better.

  Recruiting Phase 2 University of Calgary · Calgary, Alberta · NCT03214354

• Socio‑professional inclusion for young people (15–25) with childhood-onset rare genetic disabilities

  This project will try to see what makes it hard for 15–25‑year‑olds with childhood-onset rare genetic conditions to access higher education, internships, or work.

  Recruiting Imagine Institute · Paris, Île-de-France Region · NCT07527624

• FACE.S-4-KIDS: Deep phenotyping database for childhood craniofacial differences

  This project will build a detailed clinical, imaging, photographic, and genetic database to see if combining these data helps doctors better diagnose and plan care for children with craniofacial anomalies.

  Recruiting Imagine Institute · Paris · NCT07422454

• Natural history of type I interferonopathies in a European patient group

  This project will follow people with genetically confirmed type I interferonopathies across European centers to see how the disease develops and which clinical and blood markers track disease activity.

  Recruiting at 18 sites Imagine Institute · Innsbruck and 31 other locations · NCT07040774

• Research on therapeutic targets for nephronophthisis and related kidney diseases

  This study is trying to find new treatment options for nephronophthisis and related kidney diseases by testing if existing drugs can fix problems in cells affected by this genetic condition.

  Recruiting Imagine Institute · La Defense · NCT06648044

• Understanding Developmental and Epileptic Encephalopathy through Clinical Data

  This study is trying to gather and analyze health information from patients with Developmental and Epileptic Encephalopathy to better understand the condition and improve treatment options.

  Recruiting Imagine Institute · Amiens and 22 other locations · NCT06380192

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.